ATA415075A - PROCESS FOR THE MANUFACTURING OF GRANULES - Google Patents

PROCESS FOR THE MANUFACTURING OF GRANULES

Info

Publication number
ATA415075A
ATA415075A AT415075A AT415075A ATA415075A AT A415075 A ATA415075 A AT A415075A AT 415075 A AT415075 A AT 415075A AT 415075 A AT415075 A AT 415075A AT A415075 A ATA415075 A AT A415075A
Authority
AT
Austria
Prior art keywords
granules
manufacturing
Prior art date
Application number
AT415075A
Other languages
German (de)
Other versions
AT343083B (en
Original Assignee
Klinge Co Chem Pharm Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Klinge Co Chem Pharm Fab filed Critical Klinge Co Chem Pharm Fab
Publication of ATA415075A publication Critical patent/ATA415075A/en
Application granted granted Critical
Publication of AT343083B publication Critical patent/AT343083B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1641Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1694Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2/00Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
    • B01J2/16Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by suspending the powder material in a gas, e.g. in fluidised beds or as a falling curtain

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Glanulating (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT415075A 1974-06-04 1975-05-30 PROCESS FOR THE MANUFACTURING OF GRANULES AT343083B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19742426812 DE2426812A1 (en) 1974-06-04 1974-06-04 PROCESS FOR THE MANUFACTURING OF GRANULES

Publications (2)

Publication Number Publication Date
ATA415075A true ATA415075A (en) 1977-09-15
AT343083B AT343083B (en) 1978-05-10

Family

ID=5917213

Family Applications (1)

Application Number Title Priority Date Filing Date
AT415075A AT343083B (en) 1974-06-04 1975-05-30 PROCESS FOR THE MANUFACTURING OF GRANULES

Country Status (8)

Country Link
JP (1) JPS516869A (en)
AT (1) AT343083B (en)
BE (1) BE829449A (en)
DE (1) DE2426812A1 (en)
FR (1) FR2273584A1 (en)
GB (1) GB1513166A (en)
LU (1) LU72652A1 (en)
NL (1) NL7506615A (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE65045B1 (en) * 1990-04-28 1995-10-04 Takeda Chemical Industries Ltd Granulated preparations and method of producing the same
GB2287880A (en) * 1994-03-14 1995-10-04 Euro Celtique Sa Production of sustained release compositions
US5429825A (en) * 1992-06-26 1995-07-04 Mcneil-Ppc, Inc. Rotomelt granulation
EP0665010B1 (en) * 1992-10-16 2002-09-11 Nippon Shinyaku Company, Limited Method of manufacturing wax matrices
IL109460A (en) 1993-05-10 1998-03-10 Euro Celtique Sa Controlled release formulation comprising tramadol
US5891471A (en) 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
KR100354702B1 (en) 1993-11-23 2002-12-28 유로-셀티크 소시에떼 아노뉨 Manufacturing method and sustained release composition of pharmaceutical composition
US5843480A (en) 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
DE19918325A1 (en) 1999-04-22 2000-10-26 Euro Celtique Sa Extruded drug dosage form, e.g. granulate for tableting, comprising an active agent in a polysaccharide-containing matrix, giving a release profile which is controllable by extrusion conditions and/or the inclusion of additives
CA2491572C (en) 2002-07-05 2010-03-23 Collegium Pharmaceutical, Inc. Abuse-deterrent pharmaceutical compositions of opiods and other drugs
US8557291B2 (en) 2002-07-05 2013-10-15 Collegium Pharmaceutical, Inc. Abuse-deterrent pharmaceutical compositions of opioids and other drugs
US10004729B2 (en) 2002-07-05 2018-06-26 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
US8840928B2 (en) 2002-07-05 2014-09-23 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
SI1765292T1 (en) 2004-06-12 2018-04-30 Collegium Pharmaceutical, Inc. Abuse-deterrent drug formulations
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
US9737530B1 (en) 2016-06-23 2017-08-22 Collegium Pharmaceutical, Inc. Process of making stable abuse-deterrent oral formulations
CN110507658B (en) * 2019-09-18 2022-10-21 国药集团致君(深圳)制药有限公司 Cefuroxime axetil pharmaceutical composition and preparation method thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4856577A (en) * 1971-11-22 1973-08-08

Also Published As

Publication number Publication date
DE2426812A1 (en) 1976-01-02
GB1513166A (en) 1978-06-07
BE829449A (en) 1975-09-15
AT343083B (en) 1978-05-10
LU72652A1 (en) 1975-10-08
JPS516869A (en) 1976-01-20
NL7506615A (en) 1975-12-08
FR2273584A1 (en) 1976-01-02

Similar Documents

Publication Publication Date Title
AT342794B (en) Process for the production of molded parts
AT338420B (en) PROCESS FOR THE PRODUCTION OF ADRIAMYCINES
AT347130B (en) PROCESS FOR THE PRODUCTION OF TERPOLYMERISATES
AT343083B (en) PROCESS FOR THE MANUFACTURING OF GRANULES
DD127731A5 (en) PROCESS FOR THE PREPARATION OF CEPHALOSPORANSAEUREDERIVATES
ATA966275A (en) PROCESS FOR THE PREPARATION OF P-BENZOQUINONDIKETALEN
AT346850B (en) PROCESS FOR THE MANUFACTURING OF EPOXIDS
AT333774B (en) PROCESS FOR THE PREPARATION OF 3-PHENYLPYRIDAZONES
AT335989B (en) PROCESS FOR THE CONTINUOUS MANUFACTURING OF 2-ATHYLHEXANOL
AT342307B (en) PROCESS FOR THE PRODUCTION OF POLYURETHANES
AT344574B (en) Process for the production of molded blocks
DD122962A5 (en) PROCESS FOR THE PREPARATION OF HALOGENANTHRACHINONES
AT343120B (en) PROCESS FOR THE PREPARATION OF 6-CHLORO-2-CHLOROMETHYL-4-PHENYLCHINAZOLINE-3-OXIDE
AT341672B (en) PROCESS FOR THE PREPARATION OF 3-METHYLENCEPHAMSULFOXIDES
AT334909B (en) PROCESS FOR THE PREPARATION OF SUBSTITUTED THIOCARBAMINE S-ALKYLESTERS
AT339268B (en) PROCESS FOR MANUFACTURING ACETOXYBUTANOLS
AT338747B (en) PROCESS FOR THE MANUFACTURING OF BUTANDIOLS
DD122986A1 (en) PROCESS FOR THE PREPARATION OF POLYESTERAL COCOOLS
AT339925B (en) PROCESS FOR THE PRODUCTION OF BETA-CHLORATHYLTRICHLOROSILANE
AT344171B (en) PROCESS FOR THE PRODUCTION OF INDOLYL-PYRIDYL-KETONS
AT335063B (en) PROCESS FOR THE PREPARATION OF D (-) - ALFA-AMINO-P-HYDROXYBENZYLPENICILLIN
AT339269B (en) PROCESS FOR THE PRODUCTION OF PROPARGYLAMINES
AT344675B (en) PROCESS FOR THE PREPARATION OF 3-FLUORO-DL-ALANINE
DD122973A5 (en) PROCESS FOR THE PREPARATION OF 4A-ARYL-TRANSDECAHYDROISOCHINOLINES
ATA233075A (en) PROCESS FOR THE MANUFACTURING OF 16ALPHA- AND 16BETA-METHAL-9ALPHA-CHLORINE- OR -FLOUR-21- DESOXYPREDNISOLONE ESTERS AND -AETHERS